Gilead Sciences Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (422)

Latest Posts

About This Stock More About This Stock
Week In Review: $3.4 Billion Week For China Life Science Deals
Article By: ChinaBio® Today
Saturday, May 12, 2018 4:50 PM EDT
Armo Biosciences, a Bay Area immuno-oncology company, agreed to be acquired by Eli Lilly. Lilly offered to pay $50 per share for Armo, a three-fold increase from the IPO price and a 67% jump from its previous close.
In this article: AZN, LLY, ARMO, GILD
Read
Ten Stocks For Using A Benjamin Graham Value Investing Strategy
Article By: Benjamin Clark
Thursday, May 10, 2018 10:13 AM EDT
The companies in this list pass the rigorous requirements of either the Defensive Investor or the Enterprising Investor and are either fairly valued or undervalued by the market.
In this article: IVZ, BBBY, GILD, LNC, M, SIG, T, TAP, UNM, VZ
Read
Ask Slim Market Week - Friday, May 4
Video By: Steve Miller
Friday, May 4, 2018 7:23 PM EDT
The stock market dropped most of this week until Friday, dropping on news it usually wouldn't react to, but on Friday Warren Buffett added Apple shares to his portfolio lifting the Nasdaq and the overall stock market.
In this video: CAH, CAT, CMI, FLR, KORS, P, AAPL, CREE, GILD, TSLA, SPX, TPR
Watch
10 Low PE Stock Picks For The Enterprising Investor – May 2018
Article By: Benjamin Clark
Tuesday, May 1, 2018 12:39 PM EDT
I’ve selected 10 low PE stocks for the Enterprising Investor. Each company has been determined to be suitable for the Enterprising Investor and undervalued according to the ModernGraham approach.
In this article: LNC, LYB, NWL, PFG, SIG, T, VZ, BBBY, GILD, LUC
Read
10 Undervalued Stocks For The Enterprising Investor – April 2018
Article By: Benjamin Clark
Tuesday, April 17, 2018 2:10 PM EDT
There are a number of great companies in the market today.
In this article: LUCRF, SIG, GILD, LNC, LYB, BAC, MS, AMP, RF, BBBY
Read

PARTNER HEADLINES

Latest Tweets for $GILD

No tweets yet!

$GILD

Gilead Crohn's Treatment Is Not The Solution To GLD Revenue Issues
Kurt Benson 3/24/2017 10:12:59 PM

I have to agree with your assessment on $GILD. Do you know anything about $VBIO? I read a promising article here about their having a major breakthrough in #Crohn's research.

www.talkmarkets.com/.../interview-with-vitality-biopharma-inc

Not a lot of info on the company though.

Gilead Crohn's Treatment Is Not The Solution To GLD Revenue Issues
Kirk Sheffield 3/24/2017 10:11:55 PM

I think $GILD will rebound. This isn't the only product they have in their pipeline.

Gilead Crohn's Treatment Is Not The Solution To GLD Revenue Issues
Alpha Stockman 3/24/2017 10:07:45 PM

I've been rather disappointed with #Gilead myself. After reading your article, I'm planning to offload some $GILD.

Gilead Sciences Receives Canadian Approval For HIV Drug
David Reynolds 2/20/2017 10:04:11 PM

The opening up of this market for #GileadSciences should bode well for the stock $GILD.

Gilead Sciences: Cheap Growth Or Value Trap?
Karen Klein 9/13/2016 5:39:48 PM

Excellent analysis, you have effectively convinced me to change my position on #Gilead. $GILD

3 Cult Stocks To Avoid In 2015
Bruce Powers 1/26/2015 8:01:06 AM

Great article and glad to read the reasoning to consider $GILD as a safer investment short, mid and long term.

3 Cult Stocks To Avoid In 2015
BreakingBad News 1/25/2015 6:09:51 PM

Sorry all, thanks for the clarification. My bad! Now that I've read it through, it all makes total sense. $GILD, $BAC, $WFM, and $VA are my plays for 2015.

3 Cult Stocks To Avoid In 2015
BreakingBad News 1/25/2015 4:48:08 PM

I'd say this is a minority view, I've seen several others stating that $GILD was a stock to buy this year.

1 to 8 of 8 comments